GlaxoSmithKline is eyeing another indication for its Nucala (mepolizumab) biologic drug after a phase 3 trial in inflammation caused by nasal polyps hit its targets, bringing it into competition ...
Both assets are poised to enter registrational studies under accelerated approval pathways, according to Jefferies. GSK to Stay Out of Obesity—but not GLP-1s At JPM25 on Monday, GSK Chief Scientific ...
GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from existing assets. At the JPMorgan Healthcare Conference, the European healthcare giant noted there ...
Preheat oven to 350 degrees. Line a 9-inch-by-13-inch or similar baking dish with foil and spray the bottom with cooking spray. Mix together the mayonnaise and ketchup and set aside. Pull rolls ...
Learn More Pharmaceutical giant GSK is pushing the boundaries of what generative AI can achieve in healthcare areas like scientific literature review, genomic analysis and drug discovery.
The company also resolved accusations that it paid kickbacks to doctors to prescribe those drugs as well as the drugs Imitrex, Lotronex, Flovent and Valtrex. "GSK's sales force bribed physicians to ...
The deal includes an upfront payment of $1bn and an additional $150m tied to regulatory milestones. Credit: Bloomberg via Getty Images. GSK has announced a definitive agreement to acquire IDRx, a ...
Until now, sumatriptan administration takes place in tablet form, as a nasal spray or as an injection. Many migraine patients become nauseous or suffer from vomiting, which means that both tablets ...
Ltd. The funds will support the inorganic expansion strategy of Neuberg, which says it is the fourth-largest diagnostic player in India. The company, which was founded by industry veteran GSK Velu, ...
Pfizer and GSK vaccines will now be required to carry warnings that they may be tied to an increased risk of a rare neurological side effect. © 2024 Fortune Media IP ...
has approved GSK’s Nucala (mepolizumab) as an add-on treatment with intranasal corticosteroids to treat chronic rhinosinusitis with nasal polyps (CRSwNP) in the adult population. This marks the ...